Revolutionary Barcode Tool for Enhanced Cancer Diagnostics: Transforming Detection and Treatment

A new tool called Patho-DBiT from Yale uses barcode technology to improve cancer diagnosis. This tool was highlighted in a study published on September 30 in the journal Cell.

Dr. Mina Xu, a Yale professor and co-corresponding author, expressed excitement about Patho-DBiT’s capabilities. She noted, “As a physician who has been diagnosing cancer, I was surprised by how much more I can see using this pathology tool.” She believes it will significantly enhance our understanding of tumor biology and lead to more accurate diagnoses.

Patho-DBiT employs DNA barcoding to analyze the spatial distribution of RNA and proteins in tissue samples. This tool uniquely combines microfluidic devices to deliver barcodes from two directions, creating a detailed 2D map. This map can inform the development of targeted therapies tailored to individual patients.

Dr. Rong Fan, the study’s senior author and a professor at Yale, stated, “It’s the first time we can directly ‘see’ all kinds of RNA species in clinical tissue samples.” He emphasizes that this technology allows researchers to explore the complex roles of RNA molecules beyond merely identifying gene expression.

The study highlights how Patho-DBiT could access valuable information in archived tissue samples. Dr. Zhiliang Bai, the study’s first author, pointed out that many existing tissues are underutilized due to limitations in current analytical methods. He remarked, “Traditional methods can’t capture all the important information about them,” which makes Patho-DBiT an exciting development.

Looking ahead, researchers see potential for Patho-DBiT to contribute to new targeted therapies and understand how low-grade tumors develop into more aggressive forms. However, more studies are required to validate its application in clinical diagnostics.

This research involved collaboration between faculty from various Yale departments, including biomedical engineering, pathology, and genetics. Dr. Jun Lu, a co-author, noted that Patho-DBiT can also create spatial maps of noncoding RNA expression, which may play critical roles in cancer biology.

Reference: Bai Z, Zhang D, Gao Y, et al. Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues. Cell. 2024;187(23):6760-6779.e24. doi: 10.1016/j.cell.2024.09.001